Yoshioka Y

No ORCID on file · 6 papers in corpus
observational 2024
Reproductive medicine and biology ·doi:10.1002/rmb2.12560

PURPOSE: The primary objective of this investigation is to evaluate how morphological quality affects the pregnancy outcomes in euploid embryos determined by preimplantation genetic testing for aneuploidies (PGT-A). Concurrently, as a secon…

case-report 2024
International cancer conference journal ·doi:10.1007/s13691-023-00649-z

Peritoneal tuberculosis (TB) is known to mimic advanced ovarian cancer. In this case report, we describe a unique case of ovarian cancer (endometrioid carcinoma grade 3) at the International Federation of Gynecology and Obstetrics (FIGO) st…

diagnostic-accuracy 2017
Oncotarget ·doi:10.18632/oncotarget.20688

Ovarian cancer is the leading cause of gynecologic cancer mortality, due to the difficulty of early detection. Current screening methods lack sufficient accuracy, and it is still challenging to propose a new early detection method that impr…

observational 2016
Oncotarget ·doi:10.18632/oncotarget.10181

Somatic mutations in the ARID1A tumor-suppressor gene have been frequently identified in ovarian clear cell carcinoma (CCC) cases. BAF250a encoded by ARID1A is a member of the SWI/SNF complex, but the expression and mutation status of other…

case-report 2014
Pathology international ·doi:10.1111/pin.12218

A uterus-like mass is an extrauterine mass with a cavity lined by endometrial tissue and a smooth muscle layer resembling the uterine corpus. It is a rare condition of unknown histogenesis. Herein, we describe a case of clear cell carcinoma…

other 2012
Oncology letters ·doi:10.3892/ol.2012.770

In an attempt to clarify the clinical characteristics of synchronous primary endometrial and ovarian cancer (SPC), we reviewed the clinicopathological features of 13 cases treated in the Department of Gynecology and Obstetrics at Kyoto Univ…